The Intelligence from The Economist Harms weigh: AstraZeneca vaccine fears
Mar 17, 2021
Tim Cross, Technology editor for The Economist, and Gotti Epstein, China affairs editor for The Economist, dive into the wave of concerns surrounding the AstraZeneca vaccine, emphasizing its safety amidst public fears. They also explore the concept of 'hostage diplomacy' linked to China’s detention of Canadians, highlighting its impact on international relations. Additionally, the discussion shifts to the booming NFT market, examining its potential to revolutionize digital art while questioning its sustainability and environmental impact.
AI Snips
Chapters
Books
Transcript
Episode notes
Correlation vs. Causation
- Regulators distinguish between correlation and causation when evaluating vaccine side effects.
- A medical event following vaccination doesn't automatically imply causation.
Discrepancy in Blood Clot Data
- Germany and Norway reported a slight increase in rare brain blood clots after AstraZeneca vaccination.
- However, Britain, having administered more doses, hasn't observed a similar pattern.
Placebo Group Findings
- Placebo-controlled trials for the AstraZeneca vaccine showed more serious side effects in the placebo group.
- This highlights that adverse events can occur regardless of vaccination.
